Analyze Diet

Topic:Phenylbutazone

Phenylbutazone is a non-steroidal anti-inflammatory drug (NSAID) commonly used in horses to manage pain and inflammation associated with musculoskeletal disorders. It functions by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), which play a role in the inflammatory process. Phenylbutazone is administered in various formulations, including oral and injectable forms, and is often used in the treatment of conditions such as arthritis, laminitis, and soft tissue injuries. The pharmacokinetics, therapeutic effects, and potential side effects, such as gastrointestinal irritation and renal impairment, are subjects of ongoing research. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacology, clinical applications, and safety considerations of phenylbutazone in equine medicine.
Use of phenylbutazone in competitions.
The Veterinary record    March 21, 1981   Volume 108, Issue 12 248 doi: 10.1136/vr.108.12.248
Vogel C.No abstract available
Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies.
American journal of veterinary research    January 1, 1981   Volume 42, Issue 1 94-99 
Burrows GE.Phenylbutazone (PBZ), a classic anti-inflammatory and prostaglandin-synthesis inhibitor drug, was used to determine the role of prostaglandins and other mediators on the development and perpetuation of the response to intraperitoneal Escherichia coli endotoxin administration. The PBZ (15 mg/kg of body weight) was administered IV 30 minutes after endotoxin administration and was repeated later at 6 and 12 hours at a dose of 10 mg/kg. A variety of evaluation measurements (hematologic, blood glucose, pyruvate, lactate and fibrinogen, serum beta-glucuronidase, prothrombin time, blood gases, hepati...
Phenylbutazone toxicity in ponies.
The Veterinary record    January 19, 1980   Volume 106, Issue 3 68 doi: 10.1136/vr.106.3.68
Snow DH, Douglas TA, Thompson H, Parkins JJ, Holmes PH.No abstract available
Treatment and prognosis for cunean tendon bursitis-tarsitis of Standardbred horses.
Journal of the American Veterinary Medical Association    November 15, 1979   Volume 175, Issue 10 1086-1088 
Gabel AA.During 1975 and 1976, 70 Standardbred horses with cunean bursitis-tarsitis were treated by cunean tenectomy or by more conservative approaches (rested, given corticosteroid injections in the cunean bursa and distal hock articulations, given an oral course of phenylbutazone, a combination of these) or were sold. In 1975, owners were urged to have cunean tenectomy done to horses that appeared to have potential to race well, and in 1976, the more conservative methods of management and treatment were recommended. Statistical analysis of racing performance data led to the conclusion that there was ...
Phenylbutazone toxicity in ponies.
The Veterinary record    August 18, 1979   Volume 105, Issue 7 150-151 doi: 10.1136/vr.105.7.150
Lees P, Michell AR.No abstract available
Phenylbutazone toxicity in ponies.
The Veterinary record    July 14, 1979   Volume 105, Issue 2 26-30 doi: 10.1136/vr.105.2.26
Snow DH, Bogan JA, Douglas TA, Thompson H.The oral administration of phenylbutazone at a dose rate of approximately 10 mg per kg per day for seven to 14 days resulted in the development of signs of toxicity in seven of eight ponies treated. Clinical signs included anorexia, depression and abdominal oedema. Blood biochemical determinations showed a decrease in total plasma protein and calcium concentrations with an increase in urea concentration. These changes were considered indicative of water retention. Three of the ponies died during treatment following the development of shock. Shock was considered to arise from the submucosal oed...
Effect of exercise, phenylbutazone, and furosemide on the plasma renin activity and angiotensin I in horses.
American journal of veterinary research    July 1, 1979   Volume 40, Issue 7 986-990 
Purohit RC, Nachreiner RF, Humburg JM, Norwood GL, Beckett SD.Circulating concentrations of angiotensin I and plasma renin activity (PRA) were determined in 45 Thoroughbreds before prerace medication (at rest), 1 to 1 1/2 hours before racing but after prerace medication (prerace), within 15 minutes after racing (immediately postrace), and between 1 to 2 hours after racing. Angiotensin I was measured by radioimmunoassay, and PRA was determined by the rate of generation of angiotensin I in plasma incubated at 37 C. Irrespective of prerace medication, there was a marked increase in angiotensin I (0.478 +/- 0.034 to 0.848 +/- 0.051 ng/ml) and PRA (0.191 +/- ...
In vitro effects of phenylbutazone on equine chromosomes.
The Veterinary record    March 3, 1979   Volume 104, Issue 9 195-196 doi: 10.1136/vr.104.9.195
Smith AL, Lodge JR, Link RP.No abstract available
Phenylbutazone inhibition of equine platelet function.
American journal of veterinary research    February 1, 1979   Volume 40, Issue 2 265-270 
Meyers KM, Lindner C, Katz J, Grant B.Nonsteroidal anti-inflammatory drugs impair platelet aggregation and secretion in man, pigs, and rabbits and inhibit platelet thromboxane/prostaglandin synthesis. The present investigation studied the effects of phenylbutazone on platelet aggregation and bleeding times in the horse. Aggregation responses to adenosine diphosphate and collagen were markedly impaired 15 minutes and 2 hours after treatment, but 4 hours after treatment, platelet responses approximated those prior to treatment. The in vivo effect of phenylbutazone correlated with its plasma concentrations. Phenylbutazone, like aspir...
The use of phenylbutazone in the horse.
The Veterinary record    December 23, 1978   Volume 103, Issue 26-27 571 doi: 10.1136/vr.103.26-27.571
No abstract available
The use of phenylbutazone in the horse.
The Veterinary record    December 23, 1978   Volume 103, Issue 26-27 571 doi: 10.1136/vr.103.26-27.571
No abstract available
Phenylbutazone and the horse–a review.
Equine veterinary journal    July 1, 1977   Volume 9, Issue 3 105-110 doi: 10.1111/j.2042-3306.1977.tb03997.x
Jeffcott LB, Colles CM.The clinical uses and side-effects of phenylbutazone in man, horses, and other animals are reviewed. The blood dyscrasias commonly described in man have not been reported in the horse, although several of the more minor side-effects have occasionally been seen (e.g. water retention, depression, transient staggering and phlebitis). Despite the lack of documented evidence, the toxicity of phenylbutazone in the horse is considered to be lower than that in man. This may be associated with the lower dose rates normally used, the more rapid plasma clearance rate and the comparatively younger age of ...
Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
American journal of veterinary research    January 1, 1977   Volume 38, Issue 1 123-127 
Tobin T, Blake JW, Valentine R.The plasma half-life of phenylbutazone in horses was not increased after pretreatment with chloramphenicol or quinidine, but was increased after oxyphenbutazone. This increased plasma half-life after oxyphenbutazone is consistent with observations in other species and suggests that oxyphenbutazone inhibits the metabolism of phenylbutazone in horses. Lack of inhibition of phenylbutazone metabolism in the horse by chloramphenicol and quinidine is inconsistent with results obtained in other species.
Drug interactions in the horse: effect of furosemide on plasma and urinary levels of phenylbutazone.
Research communications in chemical pathology and pharmacology    October 1, 1976   Volume 15, Issue 2 257-265 
Roberts BL, Blake JW, Tobin T.Horses pretreated with 6.6 mg/kg of phenylbutazone were injected with 1 mg/kg of furosemide intravenously. Furosemide had no clinically significant effect on either plasma levels or plasma half-life of phenylbutazone. Furosemide reduced urinary levels of phenylbutazone 18-fold to concentrations which may result in inconsistent drug detection in routine screening tests. The results show that it is not possible to monitor compliance with phenylbutazone medication rules by means of urinalysis alone if the use of furosemide is permitted. Furosemide treatment, however, does not interfere with monit...
Racing problems in the U.S.A.
British journal of sports medicine    October 1, 1976   Volume 10, Issue 3 159-162 doi: 10.1136/bjsm.10.3.159
Jaggard G.The major problems of racing in the United States at the present time are caused by too much racing. This has led to too few horses and small fields. Consequently many owners and trainers are trying to enter their horses too frequently and to race them when they are not really fit to run. The desire to race horses as frequently as possible has led to constant pressure from horsemen through their organizations for so called "permissive medication". Started in the state of Colorado approximately ten years ago this has grown until finally there are only a few states, notably New York and New Jers...
Persistence of phenylbutazone in horses producing acid urines.
The Veterinary record    August 4, 1973   Volume 93, Issue 5 124-125 doi: 10.1136/vr.93.5.124
Moss MS, Haywood PE.No abstract available
A clinician’s views on the use and misuse of phenylbutazone.
Equine veterinary journal    April 5, 1972   Volume 4, Issue 2 63-65 doi: 10.1111/j.2042-3306.1972.tb03880.x
Dunn PS.No abstract available
The determination of phenylbutazone in horse plasma.
The Veterinary record    February 12, 1972   Volume 90, Issue 7 199 doi: 10.1136/vr.90.7.199
Bogan JA.No abstract available
Detection of phenylbutazone and oxyphenbutazone in the urine of thoroughbreds.
Journal of the American Veterinary Medical Association    February 15, 1970   Volume 156, Issue 4 454-456 
Finocchio EJ, Ozog FJ, Oehme FW, Johnson JH, Osbaldiston GW.No abstract available
Studies with phenylbutazone, oxyphenbutazone, and para-paradichloro phenylbutazone in horses.
The Cornell veterinarian    October 1, 1969   Volume 59, Issue 4 577-580 
Gandal CP, Dayton PG, Weiner M, Perel JM.No abstract available
Plasma and urine levels of phenylbutazone in the horse.
Journal of the American Veterinary Medical Association    July 15, 1968   Volume 153, Issue 2 195-198 
Piperno E, Ellis DJ, Getty SM, Brody TM.No abstract available
Effect of oxyphenylbutazone on surgical wounds of horses.
Journal of the American Veterinary Medical Association    March 1, 1968   Volume 152, Issue 5 487-491 
Gorman HA, Wolff WA, Frost WW, Lumb WV, Nelson AW.No abstract available
[Side-effects of phenylbutazone].
Minerva farmaceutica    September 1, 1962   Volume 11 183 
PASINI G.No abstract available
Phenylbutazone: short-term versus long-term administration to thoroughbred and standardbred horses.
Journal of the American Veterinary Medical Association    February 15, 1962   Volume 140 337-341 
GABRIEL KL, MARTIN JE.No abstract available
Drug administration to racing animals.
Journal of the American Veterinary Medical Association    March 15, 1957   Volume 130, Issue 6 240-243 
MORGAN CE.No abstract available
1 9 10 11